Accueil > Actualité
Actualite financiere : Actualite bourse

Novo Nordisk: Canada approves expanded use of Victoza.

(CercleFinance.com) - Denmark's Novo Nordisk said on Tuesday that Health Canada has approved Victoza to reduce the risk of cardiovascular death in patients with type-2 diabetes and cardiovascular diseases.


Victoza is now approved to reduce the incidence of cardiovascular death in patients with type-2 diabetes and established cardiovascular diseases when added to diet, exercise, and the current standard of care therapy.

Novo Nordisk said the product update for Victoza has been supported by results from a long-term trial that showed that Victoza reduced the risk of cardiovascular death, heart attack and non-fatal stroke by 13% versus placebo.


Copyright (c) 2017 CercleFinance.com. All rights reserved.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.